Drug Profile
Anti-ICAM-1 monoclonal antibody 1A-29
Alternative Names: 1A-29; Monoclonal antibody 1A-29Latest Information Update: 01 Aug 2002
Price :
$50
*
At a glance
- Originator Johns Hopkins University; Nonindustrial source; Pharmacia Corporation
- Developer Nonindustrial source
- Class Anti-ischaemics; Monoclonal antibodies
- Mechanism of Action Intercellular adhesion molecule 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Multiple sclerosis; Transplant rejection